• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌的血清学和组织学指标以及肿瘤体积倍增时间。

Serological and histological indices of hepatocellular carcinoma and tumor volume doubling time.

作者信息

Shingaki Naoki, Tamai Hideyuki, Mori Yoshiyuki, Moribata Kosaku, Enomoto Shotaro, Deguchi Hisanobu, Ueda Kazuki, Inoue Izumi, Maekita Takao, Iguchi Mikitaka, Kato Jun, Ichinose Masao

机构信息

Second Department of Internal Medicine, Wakayama Medical University, Wakayama City, Wakayama 641-0012, Japan.

出版信息

Mol Clin Oncol. 2013 Nov;1(6):977-981. doi: 10.3892/mco.2013.186. Epub 2013 Sep 17.

DOI:10.3892/mco.2013.186
PMID:24649280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3916198/
Abstract

Hepatocellular carcinoma (HCC) frequently develops in cirrhotic liver and is one of the most common malignancies worldwide. The tumor volume doubling time (TVDT) reflects the natural tumor growth rate and is an indicator of the biological malignant potential of a tumor. The present study aimed to elucidate the association between the serological and histological indices of HCC and TVDT. TVDT was analyzed for 53 HCCs by measuring the enlargement of the tumor diameter on dynamic computed tomography. Differences in TVDT were compared among histological grades of HCC differentiation. The α-fetoprotein (AFP) doubling time (T2AFP) for 44 HCCs with AFP levels >200 ng/ml was calculated and the differences in T2AFP were compared according to the histological grade of HCC differentiation and positivity for agglutinin-reactive fraction of α-fetoprotein (AFP-L3). Among these 44 HCCs, the correlation between T2AFP and TVDT was analyzed for the 27 tumors for which TVDT could be calculated. The mean ± standard deviation (SD) TVDT in Edmondson grade 1 (Ed1), Ed2 and Ed3 HCC was 138.3±110.3, 94.9±91.5 and 32.2±20.8 days, respectively (P<0.05). The mean ± SD T2AFP in Ed2 and Ed3 HCC was 121.0±167.5 and 37.3±24.6 days, respectively (P<0.01). TVDT and T2AFP decreased with histological dedifferentiation of HCC. The mean ± SD T2AFP in the AFP-L3-positive and -negative groups was 63.2±101.2 and 191.9±209.9 days, respectively, with a statistically significant difference between the groups (P<0.01). A significant correlation was observed between T2AFP and TVDT (correlation coefficient, 0.70; P<0.01). A significant correlation was also observed among TVDT, serological indices and histological grades of HCC differentiation. A short T2AFP and/or AFP-L3-positivity were shown to reflect a poorly differentiated HCC histopathology and a higher malignant potential.

摘要

肝细胞癌(HCC)常发生于肝硬化肝脏,是全球最常见的恶性肿瘤之一。肿瘤体积倍增时间(TVDT)反映肿瘤自然生长速率,是肿瘤生物学恶性潜能的一个指标。本研究旨在阐明HCC的血清学和组织学指标与TVDT之间的关联。通过在动态计算机断层扫描上测量肿瘤直径增大情况,对53例HCC的TVDT进行分析。比较HCC不同分化组织学分级的TVDT差异。计算44例甲胎蛋白(AFP)水平>200 ng/ml的HCC的AFP倍增时间(T2AFP),并根据HCC分化组织学分级和甲胎蛋白凝集素反应性部分(AFP-L3)阳性情况比较T2AFP差异。在这44例HCC中,对27例可计算TVDT的肿瘤分析T2AFP与TVDT之间的相关性。Edmondson 1级(Ed1)、Ed2和Ed3级HCC的平均±标准差(SD)TVDT分别为138.3±110.3、94.9±91.5和32.2±20.8天(P<0.05)。Ed2和Ed3级HCC的平均±SD T2AFP分别为121.0±167.5和37.3±24.6天(P<0.01)。TVDT和T2AFP随HCC组织学去分化而降低。AFP-L3阳性和阴性组的平均±SD T2AFP分别为63.2±101.2和191.9±209.9天,两组间差异有统计学意义(P<0.01)。观察到T2AFP与TVDT之间存在显著相关性(相关系数,0.70;P<0.01)。在TVDT、血清学指标和HCC分化组织学分级之间也观察到显著相关性。短的T2AFP和/或AFP-L3阳性表明HCC组织病理学分化差且恶性潜能更高。

相似文献

1
Serological and histological indices of hepatocellular carcinoma and tumor volume doubling time.肝细胞癌的血清学和组织学指标以及肿瘤体积倍增时间。
Mol Clin Oncol. 2013 Nov;1(6):977-981. doi: 10.3892/mco.2013.186. Epub 2013 Sep 17.
2
Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma.豆凝集素反应性甲胎蛋白和维生素K缺乏诱导蛋白II是预后不良的潜在指标:手术切除肝细胞癌的组织病理学研究
J Gastroenterol. 2007 Dec;42(12):962-8. doi: 10.1007/s00535-007-2117-x. Epub 2007 Dec 25.
3
Relationship between Lens culinaris agglutinin reactive alpha-fetoprotein and biological features of hepatocellular carcinoma.豆凝集素反应性甲胎蛋白与肝细胞癌生物学特性的关系
Kurume Med J. 1998;45(1):113-20. doi: 10.2739/kurumemedj.45.113.
4
Assessment of hepatocellular carcinomas using conventional magnetic resonance imaging correlated with histological differentiation and a serum marker of poor prognosis.应用常规磁共振成像评估肝细胞癌与组织学分化及预后不良的血清标志物的相关性。
Hepatol Int. 2011 Jun;5(2):730-7. doi: 10.1007/s12072-010-9245-8. Epub 2011 Jan 9.
5
Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.肿瘤体积倍增时间作为肝细胞癌患者的动态预后标志物
Dig Dis Sci. 2017 Oct;62(10):2923-2931. doi: 10.1007/s10620-017-4708-6. Epub 2017 Aug 16.
6
Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis.肝细胞癌肿瘤体积倍增时间:系统评价和荟萃分析。
Gut. 2021 Feb;70(2):401-407. doi: 10.1136/gutjnl-2020-321040. Epub 2020 May 12.
7
Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma.肝细胞癌患者血清甲胎蛋白中豆凝集素反应性部分的临床意义
Int J Oncol. 2002 Feb;20(2):305-9.
8
The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.豆凝集素反应性甲胎蛋白在肝细胞癌诊断中的效用:在美国转诊人群中的评估
Clin Gastroenterol Hepatol. 2007 Mar;5(3):394-402; quiz 267. doi: 10.1016/j.cgh.2006.12.005.
9
[The studies on early warning of Lens culinaris-reactive alpha-Fetoprotein (AFP-L3) detecting in primary hepatocellular carcinoma].[扁豆凝集素反应性甲胎蛋白(AFP-L3)检测在原发性肝细胞癌早期预警中的研究]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008 Oct;22(5):336-8.
10
Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection.用于检测肝细胞癌的高敏甲胎蛋白、甲胎蛋白的豆凝集素反应性组分及异常凝血酶原。
Hepatol Res. 2016 Mar;46(3):E130-5. doi: 10.1111/hepr.12544. Epub 2015 Jul 6.

引用本文的文献

1
Analysis of factors influencing tumor volume doubling time in hepatocellular carcinoma and its predictive value for progression-free survival.肝细胞癌肿瘤体积倍增时间的影响因素分析及其对无进展生存期的预测价值
Sci Rep. 2025 Jul 16;15(1):25840. doi: 10.1038/s41598-025-06349-3.
2
Quantifying the natural growth rate of hepatocellular carcinoma: A real-world retrospective study in southwestern China.量化肝细胞癌的自然生长率:中国西南部的一项真实世界回顾性研究。
World J Hepatol. 2024 May 27;16(5):800-808. doi: 10.4254/wjh.v16.i5.800.
3
Clinicopathological Aspects and Inflammation-Immune Markers in Alcohol and/or Hepatitis C Virus-Induced Hepatocellular Carcinoma Patients Treated With Sorafenib.索拉非尼治疗酒精性和/或丙型肝炎病毒诱导的肝细胞癌患者的临床病理特征及炎症免疫标志物
Gastroenterology Res. 2024 Feb;17(1):23-31. doi: 10.14740/gr1689. Epub 2024 Feb 28.
4
LI-RADS threshold growth based on tumor growth rate can improve the diagnosis of hepatocellular carcinoma ≤ 3.0 cm.基于肿瘤生长率的LI-RADS阈值增长可改善对≤3.0厘米肝细胞癌的诊断。
Eur Radiol. 2024 Feb;34(2):1210-1218. doi: 10.1007/s00330-023-10092-6. Epub 2023 Aug 17.
5
Value of Non-tumoral Liver Volume in the Prognosis of Large Hepatocellular Carcinoma Patients After R0 Resection.非肿瘤性肝体积在大肝细胞癌患者R0切除术后预后中的价值
J Clin Transl Hepatol. 2023 Jun 28;11(3):560-571. doi: 10.14218/JCTH.2022.00170. Epub 2022 Aug 30.
6
Should Threshold Growth Be Considered a Major Feature in the Diagnosis of Hepatocellular Carcinoma Using LI-RADS?在使用LI-RADS诊断肝细胞癌时,阈值生长是否应被视为主要特征?
Korean J Radiol. 2021 Oct;22(10):1628-1639. doi: 10.3348/kjr.2020.1341. Epub 2021 Jul 14.
7
CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017-Can Things Be Put Together?CT/MRI版LI-RADS v2018与CEUS版LI-RADS v2017——能否整合?
Biology (Basel). 2021 May 6;10(5):412. doi: 10.3390/biology10050412.
8
Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis.肝细胞癌肿瘤体积倍增时间:系统评价和荟萃分析。
Gut. 2021 Feb;70(2):401-407. doi: 10.1136/gutjnl-2020-321040. Epub 2020 May 12.
9
Histology of Hepatocellular Carcinoma: Association with Clinical Features, Radiological Findings, and Locoregional Therapy Outcomes.肝细胞癌的组织学:与临床特征、影像学表现及局部区域治疗结果的关联
J Clin Imaging Sci. 2019 Nov 18;9:52. doi: 10.25259/JCIS_111_2019. eCollection 2019.
10
Hepatocellular Carcinoma: State of the Art Imaging and Recent Advances.肝细胞癌:最新影像学技术与近期进展
J Clin Transl Hepatol. 2019 Mar 28;7(1):72-85. doi: 10.14218/JCTH.2018.00032. Epub 2019 Feb 17.

本文引用的文献

1
Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small (≤2 cm), indeterminate nodule: growth rate and optimal interval time for imaging follow-up.在多排探测器对比增强计算机断层扫描或钆增强磁共振成像中表现为小(≤2 cm)、不确定结节的肝细胞癌:生长速率及影像随访的最佳间隔时间
J Comput Assist Tomogr. 2012 Jan-Feb;36(1):20-5. doi: 10.1097/RCT.0b013e31823ed462.
2
Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma.术前肿瘤标志物倍增时间是预测肝癌肝切除术后复发和预后的有用指标。
J Surg Oncol. 2010 Oct 1;102(5):490-6. doi: 10.1002/jso.21451.
3
Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma.豆凝集素反应性甲胎蛋白和维生素K缺乏诱导蛋白II是预后不良的潜在指标:手术切除肝细胞癌的组织病理学研究
J Gastroenterol. 2007 Dec;42(12):962-8. doi: 10.1007/s00535-007-2117-x. Epub 2007 Dec 25.
4
Clinicopathologic features of poorly differentiated hepatocellular carcinoma.低分化肝细胞癌的临床病理特征
J Surg Oncol. 2007 Mar 15;95(4):311-6. doi: 10.1002/jso.20661.
5
Growth rate of hepatocellular carcinoma: evaluation with serial computed tomography or magnetic resonance imaging.肝细胞癌的生长速率:通过系列计算机断层扫描或磁共振成像进行评估
J Comput Assist Tomogr. 2005 Jul-Aug;29(4):425-9. doi: 10.1097/01.rct.0000164036.85327.05.
6
Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma.切除的孤立性小肝癌的临床病理特征及预后因素
Hepatogastroenterology. 2005 Jul-Aug;52(64):1163-7.
7
Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.豆凝集素反应性甲胎蛋白与肝细胞癌病理特征的关系
Liver Int. 2005 Aug;25(4):848-53. doi: 10.1111/j.1478-3231.2005.01111.x.
8
Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis.肿瘤倍增时间可预测手术后的复发情况,并描述肝硬化患者肝细胞癌的组织学模式。
J Hepatol. 2005 Aug;43(2):310-6. doi: 10.1016/j.jhep.2005.03.014.
9
A biomathematical approach to clinical tumor growth.一种临床肿瘤生长的生物数学方法。
Cancer. 1961 Nov-Dec;14:1272-94. doi: 10.1002/1097-0142(196111/12)14:6<1272::aid-cncr2820140618>3.0.co;2-h.
10
Observations on growth rates of human tumors.关于人类肿瘤生长速率的观察
Am J Roentgenol Radium Ther Nucl Med. 1956 Nov;76(5):988-1000.